Chromium levels in insulin-sensitive tissues and the thigh bone are modulated by prednisolone and high-fat diets in mice

BioMetals

Volumn 26, Issue 2, 2013, Pages 347-354

  Chen, Po Wen ^a   Lin, Chang ^b   Chen, Chung De ^b   Chen, Wen Ying ^b   Mao, Frank Chiahung ^b  

^a NURSING AND MANAGEMENT COLLEGE   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Chromium; Glucocorticoids; Insulin; Obese mice; Prednisolone; Trace elements

Indexed keywords

CHROMIUM; GLUCOSE; INSULIN; PREDNISOLONE; TRIACETIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BONE LEVEL; CONTROLLED STUDY; DIET RESTRICTION; FEMUR; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID DIET; LIVER LEVEL; MOUSE; MUSCLE LEVEL; NONHUMAN; SINGLE DRUG DOSE; TISSUE DISTRIBUTION;

ADIPOSE TISSUE; ANIMALS; CHROMIUM; DIET, HIGH-FAT; INSULIN RESISTANCE; MICE; MICE, INBRED C57BL; PREDNISOLONE; THIGH;

ANIMALIA; MUS;

EID: 84877874366     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-013-9621-7     Document Type: Article

References (56)

1. Albreda M, Rodriguez-Espinosa J, Murugo M, Leiva AD, Corcoy R (2000) Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 43:1507-1511
2. Anderson RA (1997) Chromium as an essential nutrient for humans. Regul Toxicol Pharmacol 26(1):S35-S41
3. Arnaud CD, Sanchez SD (1990) The role of calcium in osteoporosis. Annu Rev Nutr 10:397-414. doi: 10.1146/annurev.nu.10.070190.002145
4. Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci (Lond) 94(6):557-572
5. Bonacci JV, Harris T, Wilson JW, Stewart AG (2003) Collagen-induced resistance to glucocorticoid anti-mitogenic actions: a potential explanation of smooth muscle hyperplasia in the asthmatic remodelled airway. Br J Pharmacol 138(7):1203-1206
6. Borguet F, Cornelis R, Lameire N (1990) Speciation of chromium in plasma and liver tissue of endstage renal failure patients on continuous ambulatory peritoneal dialysis. Biol Trace Elem Res 26-27:449-460
7. Boyle PJ, Cryer PE (1991) Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia. Am J Physiol 260(3 Pt 1):E395-E402
8. Brown RO, Forloines-Lynn S, Cross RE, Heizer WD (1986) Chromium deficiency after long-term total parenteral nutrition. Dig Dis Sci 31(6):661-664
9. Canalis E (1996) Clinical review 83: mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81(10):3441-3447
10. Cefalu WT, Wang ZQ, Zhang XH, Baldor LC, Russell JC (2002) Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats. J Nutr 132(6):1107-1114
11. Chen G, Liu P, Pattar GR, Tackett L, Bhonagiri P, Strawbridge AB, Elmendorf JS (2006) Chromium activates glucose transporter 4 trafficking and enhances insulin-stimulated glucose transport in 3T3-L1 adipocytes via a cholesterol-dependent mechanism. Mol Endocrinol 20(4):857-870. doi: 10.1210/me.2005-0255
12. Chen WY, Chen CJ, Liao JW, Mao FC (2009a) Chromium attenuates hepatic damage in a rat model of chronic cholestasis. Life Sci 84(17-18):606-614. doi: 10.1016/j.lfs.2009.02.003
13. Chen WY, Chen CJ, Liu CH, Mao FC (2009b) Chromium supplementation enhances insulin signalling in skeletal muscle of obese KK/HlJ diabetic mice. Diabetes Obes Metab 11(4):293-303
14. Chen WY, Chen CJ, Liu CH, Mao FC (2010) Chromium attenuates high-fat diet-induced nonalcoholic fatty liver disease in KK/HlJ mice. Biochem Biophys Res Commun 397(3):459-464
15. Clodfelder BJ, Vincent JB (2005) The time-dependent transport of chromium in adult rats from the bloodstream to the urine. J Biol Inorg Chem 10(4):383-393
16. Clodfelder BJ, Emamaullee J, Hepburn DD, Chakov NE, Nettles HS, Vincent JB (2001) The trail of chromium(III) in vivo from the blood to the urine: the roles of transferrin and chromodulin. J Biol Inorg Chem 6(5-6):608-617
17. Clore JN, Thurby-Hay L (2009) Glucocorticoid-induced hyperglycemia. Endocr Pract 15(5):469-474
18. Coutinho AE, Chapman KE (2011) The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights. Mol Cell Endocrinol 335(1):2-13
19. De Feo P, Perriello G, Torlone E, Ventura MM, Fanelli C, Santeusanio F, Brunetti P, Gerich JE, Bolli GB (1989) Contribution of cortisol to glucose counterregulation in humans. Am J Physiol 257(1 Pt 1):E35-E42
20. Delany AM, Dong Y, Canalis E (1994) Mechanisms of glucocorticoid action in bone cells. J Cell Biochem 56(3):295-302. doi: 10.1002/jcb.240560304
21. Di Bona KR, Love S, Rhodes NR, McAdory D, Sinha SH, Kern N, Kent J, Strickland J, Wilson A, Beaird J, Ramage J, Rasco JF, Vincent JB (2011) Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet. J Biol Inorg Chem 16(3):381-390
22. Freund H, Atamian S, Fischer JE (1979) Chromium deficiency during total parenteral nutrition. JAMA 241(5):496-498
23. Gulko PS, Mulloy AL (1996) Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment. Clin Exp Rheumatol 14(2):199-206
24. Gur A, Colpan L, Nas K, Cevik R, Sarac J, Erdogan F, Duz MZ (2002) The role of trace minerals in the pathogenesis of postmenopausal osteoporosis and a new effect of calcitonin. J Bone Miner Metab 20(1):39-43. doi: 10.1007/s007740200005
25. Heaney RP, Gallagher JC, Johnston CC, Neer R, Parfitt AM, Whedon GD (1982) Calcium nutrition and bone health in the elderly. Am J Clin Nutr 36(5 Suppl):986-1013
26. Jain SK, Rains JL, Croad JL (2007) Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-alpha, IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats. Free Radic Biol Med 43(8):1124-1131. doi: 10.1016/j.freeradbiomed.2007.05.019
27. Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A (1977) Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. Am J Clin Nutr 30(4):531-538
28. Khaleeli AA, Edwards RH, Gohil K, McPhail G, Rennie MJ, Round J, Ross EJ (1983) Corticosteroid myopathy: a clinical and pathological study. Clin Endocrinol 18(2):155-166
29. Komorowski JR, Tuzcu M, Sahin N, Juturu V, Orhan C, Ulas M, Sahin K (2012) Chromium picolinate modulates serotonergic properties and carbohydrate metabolism in a rat model of diabetes. Biol Trace Elem Res. doi: 10.1007/s12011-012-9393-x
30. Krol E, Krejpcio Z (2011) Evaluation of anti-diabetic potential of chromium(III) propionate complex in high-fat diet fed and STZ injected rats. Food Chem Toxicol 49(12):3217-3223. doi: 10.1016/j.fct.2011.09.006
31. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112(5):352-364
32. Lukert BP, Raisz LG (1994) Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 20(3):629-650
33. Mao XQ, Wu Y, Wu K, Liu M, Zhang JF, Zou F, Ou-Yang JP (2007) Astragalus polysaccharide reduces hepatic endoplasmic reticulum stress and restores glucose homeostasis in a diabetic KKAy mouse model. Acta Pharmacol Sin 28:1947-1956
34. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28(7):412-419
35. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: an update. Trends Endocrinol Metab 17(4):144-149
36. McCarty MF (1995) Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. Med Hypotheses 45(3):241-246
37. McMahon M, Gerich J, Rizza R (1988) Effects of glucocorticoids on carbohydrate metabolism. Diabetes Metab Rev 4(1):17-30
38. Morris BW, Griffiths H, Kemp GJ (1988) Effect of glucose loading on concentrations of chromium in plasma and urine of healthy adults. Clin Chem 34(6):1114-1116
39. Morris BW, MacNeil S, Stanley K, Gray TA, Fraser R (1993) The inter-relationship between insulin and chromium in hyperinsulinaemic euglycaemic clamps in healthy volunteers. J Endocrinol 139(2):339-345
40. Olbricht T, Benker G (1993) Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases. J Intern Med 234(3):237-244
41. Phung OJ, Quercia RA, Keating K, Baker WL, Bell JL, White CM, Coleman CI (2010) Improved glucose control associated with i.v. chromium administration in two patients receiving enteral nutrition. Am J Health Syst Pharm 67(7):535-541. doi: 10.2146/ajhp090109
42. Rockall AG, Sohaib SA, Evans D, Kaltsas G, Isidori AM, Monson JP, Besser GM, Grossman AB, Reznek RH (2003) Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome. Eur J Endocrinol 149(6):561-567
43. Sahin K, Tuzcu M, Orhan C, Agca CA, Sahin N, Guvenc M, Krejpcio Z, Staniek H, Hayirli A (2011) The effects of chromium complex and level on glucose metabolism and memory acquisition in rats fed high-fat diet. Biol Trace Elem Res 143(2):1018-1030. doi: 10.1007/s12011-010-8905-9
44. Saklatvala J (2002) Glucocorticoids: do we know how they work? Arthritis Res 4(3):146-150
45. Saltman PD, Strause LG (1993) The role of trace minerals in osteoporosis. J Am Coll Nutr 12(4):384-389
46. Schacke H, Docke WD, Asadullah K (2002) Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96(1):23-43
47. Selcuk MY, Aygen B, Dogukan A, Tuzcu Z, Akdemir F, Komorowski JR, Atalay M, Sahin K (2012) Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-kappaB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats. Nutr Metab (Lond) 9(1):30. doi: 10.1186/1743-7075-9-30
48. Stahn C, Lowenberg M, Hommes DW, Buttgereit F (2007) Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonists. Mol Cell Endocrinol 275(1-2):71-78
49. Striffler JS, Law JS, Polansky MM, Bhathena SJ, Anderson RA (1995) Chromium improves insulin response to glucose in rats. Metabolism 44(10):1314-1320
50. Sun Y, Ramirez J, Woski SA, Vincent JB (2000) The binding of trivalent chromium to low-molecular-weight chromium-binding substance (LMWCr) and the transfer of chromium from transferrin and chromium picolinate to LMWCr. J Biol Inorg Chem 5(1):129-136
51. Taskinen MR, Nikkila EA, Pelkonen R, Sane T (1983) Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 57(3):619-626
52. van Raalte DH, Ouwens DM, Diamant M (2009) Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options? Eur J Clin Invest 39(2):81-93
53. Vincent JB (2000) The biochemistry of chromium. J Nutr 130(4):715-718
54. Vogeser M, Knig D, Frey I, Predel HG, Parhofer KG, Berg A (2007) Fasting serum insulin and the homeostasis model of insulin resistance (HOM-IR) in the monitoring of lifestyle interventions in obese persons. Clin Biochem 40:964-968
55. Wajchenberg BL (2000) Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 21(6):697-738
56. Wang ZQ, Qin J, Martin J, Zhang XH, Sereda O, Anderson RA, Pinsonat P, Cefalu WT (2007) Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation. Metabolism 56(12):1652-1655. doi: 10.1016/j.metabol.2007.07.007